MoneyWorks4Me

Lincoln Pharmaceuticals informs about standalone and consolidated financial results

21 Jun 2018 Evaluate

Pursuant to Regulation 33(3)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company will continue to submit Quarterly /Year to Date Standalone and Consolidated Financial Results for the Financial Year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

618.00 6.10 (1.00%)
25-Aug-2026 14:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.10
Dr. Reddys Labs. 1186.40
Cipla 1414.80
Lupin 2174.50
Zydus Lifesciences 1113.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: